Plain-English translation of NCT02355457 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are looking for new biological markers—essentially early warning signs in your blood—that could help doctors better identify who is at risk for a heart attack. This study will collect blood samples, genetic information, and health details from about 5,000 people who come to the hospital with chest pain or suspected heart attack symptoms. By studying these samples, doctors hope to develop better tools to predict heart attacks and understand what factors (genetics, lifestyle, social circumstances) put people at highest risk.
Current methods for detecting heart attacks and predicting risk don't catch everyone who is in danger, and they don't account for all the different factors that affect each person's risk. This study aims to discover new biological markers and improve risk assessment so doctors can identify at-risk patients earlier and potentially prevent heart attacks before they happen.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have blood samples taken and answer questions about your health, lifestyle, and background during your hospital visit. After you leave the hospital, the research team will contact you by phone for follow-up conversations at 30 days, 6 months, 2 years, and 4 years to see how you are doing and gather more information about your health. Your blood samples and genetic information will be studied to help identify new warning signs of heart attacks.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Germany
Universitätsklinikum Hamburg-Eppendorf
Enrollment target
~5,000 participants
Started
July 2013
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Johannes T Neumann, MD
UHZ
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.